By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KaloBios Pharmaceuticals, Inc. 

260 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-243-3100 Fax: 650-243-3260



Company News
Biotech's Bad Boy Martin Shkreli Named CEO of KaloBios (KBIO) 11/20/2015 5:45:36 AM
KaloBios (KBIO) Comes Alive Again After Turing Pharma's Martin Shkreli Takes Stake 11/19/2015 6:26:31 AM
Once Promising Bay Area KaloBios (KBIO) to Shut Down, Liquidate Assets 11/16/2015 6:05:57 AM
South San Francisco's KaloBios (KBIO) Slashes 61% of Workforce, Considers Sale 11/6/2015 6:06:31 AM
KaloBios Pharmaceuticals, Inc. (KBIO) To Present At 14th Annual BIO Investor Forum 10/16/2015 12:11:18 PM
KaloBios Pharmaceuticals, Inc. (KBIO) Reports Second Quarter Financial Results And Provides Clinical Update 8/10/2015 6:55:29 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Regains Compliance With NASDAQ Minimum Bid Price Requirement 7/30/2015 10:53:40 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Announces FDA Clearance Of Investigational New Drug Application For KB003 In Patients With Chronic Myelomonocytic Leukemia 7/29/2015 11:43:14 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Announces Shareholders And Board Of Directors Approval Of Reverse Stock Split 7/13/2015 6:28:06 AM
KaloBios Pharmaceuticals, Inc. (KBIO) To Present At The JMP Securities Life Sciences Conference 6/18/2015 6:52:10 AM